Thor Medical wins three-year deal to supply isotopes in UK

Thor Medical ASA has entered into a three-year agreement to supply its proprietary alpha-particle emitters, used in targeted cancer therapies, for use in the United Kingdom. The contract follows the opening of its AlphaOne production facility.

Detected & updated continuously · Source: Nebula